Orion Biotech Opportunities (Orion Biotech Opportunities) Change In Payables And Accrued Expense : $0.06 Mil (TTM As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Change In Payables And Accrued Expense?

Orion Biotech Opportunities's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2022 was $0.08 Mil. It means Orion Biotech Opportunities's Accounts Payable & Accrued Expense increased by $0.08 Mil from Sep. 2022 to Dec. 2022 .

Orion Biotech Opportunities's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was $0.06 Mil. It means Orion Biotech Opportunities's Accounts Payable & Accrued Expense increased by $0.06 Mil from Dec. 2021 to Dec. 2022 .

Orion Biotech Opportunities Change In Payables And Accrued Expense Historical Data

The historical data trend for Orion Biotech Opportunities's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Change In Payables And Accrued Expense Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Change In Payables And Accrued Expense

0.06

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Change In Payables And Accrued Expense	Get a 7-Day Free Trial			-	0.03	-0.07	0.02	0.08

Orion Biotech Opportunities Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06 Mil.

Orion Biotech Opportunities Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.